Skip to main content

A31 (Oxybutynin Chloride Extended-Release 5 mg)

Pill with imprint A31 is Purple, Round and has been identified as Oxybutynin Chloride Extended-Release 5 mg. It is supplied by Amneal Pharmaceuticals of New York, LLC.

Oxybutynin is used in the treatment of urinary frequency; urinary incontinence; neurogenic detrusor overactivity; dysuria and belongs to the drug class urinary antispasmodics. There is no proven risk in humans during pregnancy. Oxybutynin 5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for A31

Oxybutynin chloride extended-release 5 mg A31
Oxybutynin chloride extended-release 5 mg A31
Oxybutynin chloride extended-release 5 mg A31

Oxybutynin Chloride Extended-Release

5 mg
Rx and/or OTC
Drug Class
Urinary antispasmodics
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Amneal Pharmaceuticals of New York, LLC
Inactive Ingredients
methacrylic acid - ethyl acrylate copolymer (1:1) type a, hydrogenated cottonseed oil, hypromelloses, isopropyl alcohol, lactose monohydrate, microcrystalline cellulose, magnesium silicate, triethyl citrate, FD&C Blue No. 1, D&C Red No. 27, polysorbate 80, sodium lauryl sulfate

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
65162-0371 Amneal Pharmaceuticals LLC
42291-0540 (Discontinued) AvKare, Inc.
10135-0609 Marlex Pharmaceuticals Inc.
00904-6570 Major Pharmaceuticals

Get help with Imprint Code FAQs.

Related images for "A31"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.